Discontinued — last reported Q3 '25
Non-Current Assets
Other Non-Current Assets
Royalty Pharma Other Non-Current Assets increased by 2.1% to $16.54B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.0%, from $15.03B to $16.54B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 5.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2021
Last reportedQ3 2025
How to read this metric
Significant fluctuations may warrant investigation into the nature of the underlying assets, such as changes in long-term investments or non-core holdings.
Detailed definition
This represents a catch-all category for long-term assets that do not fit into standard classifications like property, p...
Peer comparison
Common in most balance sheets as a residual category for non-material long-term items.
Metric ID:
other_non_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.93B | $14.01B | $13.72B | $13.47B | $13.42B | $14.29B | $13.49B | $13.66B | $13.27B | $13.23B | $14.09B | $13.47B | $13.89B | $14.97B | $15.13B | $15.03B | $15.13B | $15.76B | $16.21B | $16.54B |
| QoQ Change | — | +8.4% | -2.1% | -1.8% | -0.3% | +6.4% | -5.6% | +1.3% | -2.9% | -0.3% | +6.5% | -4.4% | +3.2% | +7.8% | +1.1% | -0.6% | +0.7% | +4.2% | +2.8% | +2.1% |
| YoY Change | — | — | — | — | +3.8% | +2.0% | -1.6% | +1.4% | -1.2% | -7.4% | +4.4% | -1.4% | +4.7% | +13.1% | +7.4% | +11.6% | +9.0% | +5.3% | +7.1% | +10.0% |
Range$12.93B – $16.54B
CAGR+5.3%
Avg YoY Growth+4.3%
Median YoY Growth+4.6%
Current Streak4 quarters growth
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's other non-current assets?
- Royalty Pharma (RPRX) reported other non-current assets of $16.54B in Q1 2026.
- How has Royalty Pharma's other non-current assets changed year-over-year?
- Royalty Pharma's other non-current assets increased by 10.0% year-over-year, from $15.03B to $16.54B.
- What is the long-term trend for Royalty Pharma's other non-current assets?
- Over 5 years (2020 to 2025), Royalty Pharma's other non-current assets has grown at a 5.6% compound annual growth rate (CAGR), from $12.37B to $16.21B.
- What does other non-current assets mean?
- Miscellaneous long-term assets that do not fall into major categories like property or investments.